New antibody BNT351 enters first human trials for HIV
NCT ID NCT07392372
First seen Feb 06, 2026 · Last updated May 22, 2026 · Updated 16 times
Summary
This early-stage study tests a new antibody called BNT351 in up to 61 adults, both with and without HIV. The main goal is to check safety and how the body processes the antibody. In people with HIV, researchers will also measure if the antibody can lower the amount of virus in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CRS Mannheim
RECRUITINGMannheim, 68167, Germany
-
Johns Hopkins
RECRUITINGBaltimore, Maryland, 21205-1832, United States
-
UK Köln
NOT_YET_RECRUITINGCologne, 50937, Germany
Conditions
Explore the condition pages connected to this study.